Clorox Reports Q4 and FY24 Results, Provides FY25 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Clorox (CLX) PT Lowered to $140 at Evercore ISI
August 2, 2024 5:54 AM EDTEvercore ISI analyst Javier Escalante lowered the price target on Clorox (NYSE: CLX) to $140.00 (from $142.00) while maintaining a Underperform rating.
The analyst comments "Clorox beat this 4Q F24 on better gross margins, even as U.S. sales fell by 4% while consensus modeled flat. The controversy resides within Cloroxs most competitive household businesses,... More
Clorox (CLX) PT Raised to $148 at Jefferies
August 2, 2024 5:13 AM EDTJefferies analyst Kaumil Gajrawala raised the price target on Clorox (NYSE: CLX) to $148.00 (from $147.00) while maintaining a Hold rating.
The analyst comments "Clorox's F4Q results were mixed (top-line missed / EPS great on high margin expansion), while its F25 EPS outlook was above... More
Clorox (CLX) Tops Q4 EPS by 27c, Offers Guidance
August 1, 2024 4:13 PM EDTClorox (NYSE: CLX) reported Q4 EPS of $1.82, $0.27 better than the analyst estimate of $1.55. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.95 billion.
GUIDANCE:
Clorox sees FY2025 EPS of $6.55-$6.80, versus the consensus of $6.45.
Net sales are expected to be flat to down 2% compared to the prior year. Organic sales are expected to be up... More